Adaptive Radiotherapy Software Market Overview, Analysis And Demand By 2034


Claim 30% Off With Code ONLINE30 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights

How Is the Adaptive Radiotherapy Software Market Growth Forecast from 2025 to 2029?
The adaptive radiotherapy software market size has grown rapidly in recent years. It will grow from $0.62 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing regulatory approvals, rising trend of combining imaging modalities, growing adoption of image-guided radiotherapy, increasing need to reduce radiation exposure to healthy tissues, and increasing availability of cloud-based radiotherapy solutions.

The adaptive radiotherapy software market size is expected to see rapid growth in the next few years. It will grow to $1.20 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing adoption of precision radiotherapy techniques, rising demand for personalized cancer treatment plans, growing investment in oncology healthcare infrastructure, rising prevalence of cancer, and growing awareness among clinicians. Major trends in the forecast period include advancements in imaging technologies, developments in cloud-based software platforms, technology integration for image-guided radiotherapy, advancements in automation algorithms, and integration of multi-modality imaging data.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28114&type=smp

What Are the Key Growth Factors Supporting the Adaptive Radiotherapy Software Market Expansion?
The rising number of cancer cases is expected to propel the growth of the adaptive radiotherapy software market going forward. Cancer cases refers to the number of individuals diagnosed with cancer in a specific population over a defined period. Cancer cases are increasing because aging populations have a higher risk of accumulating genetic mutations over time, leading to more diagnoses. Adaptive radiotherapy software helps cancer cases by adjusting radiation treatment in real time based on changes in tumor size, shape, and patient anatomy, improving precision, maximizing tumor targeting, and minimizing damage to healthy tissues. For instance, in October 2022, according to Macmillan Cancer Support, a UK-based charity providing comprehensive support to individuals affected by cancer, including healthcare, information, and financial assistance. The estimated number of people living with cancer in the UK is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040, from the current estimate of 3 million. Therefore, the rising number of cancer cases is driving the growth of the adaptive radiotherapy software market.

What Segments Are Covered in the Adaptive Radiotherapy Software Market Report?
The adaptive radiotherapy software market covered in this report is segmented as

1) By Component: Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Prostate Cancer, Head And Neck Cancer, Breast Cancer, Lung Cancer, Other Applications
4) By End User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users

Subsegments:
1) By Software: Treatment Planning Software, Workflow Management Software, Imaging And Visualization Software
2) By Services: Implementation And Integration Services, Maintenance And Consulting Services, Training And Support Services

How Are Current Trends Influencing the Adaptive Radiotherapy Software Market Growth?
Major companies operating in the adaptive radiotherapy software market are focusing on developing technological advancements such as AI-powered, adaptive CT-Linac to enhance real-time tumor targeting, improve treatment precision, and optimize patient outcomes. AI-powered, adaptive CT-Linac refers to a radiation therapy system that combines computed tomography (CT) imaging with a linear accelerator (Linac), using artificial intelligence (AI) to adapt and optimize radiation delivery in real time based on changes in tumor size, shape, and position during treatment. For instance, in May 2024, Elekta AB, a Sweden-based medication company, launched Evo, designed for precise and efficient radiotherapy treatments. It is designed to deliver highly personalized and precise cancer radiation therapy. It offers advanced AI-enhanced imaging, enabling clinicians to visualize tumors with exceptional clarity and adapt treatments in real time or between sessions. Evo aims to improve treatment accuracy, reduce side effects, and enhance patients’ quality of life, while allowing clinics to adopt innovative technology at their own pace.

Who Are the Key Players Driving the Adaptive Radiotherapy Software Market?
Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brain lab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.

Get the full adaptive radiotherapy software market report here:
https://www.thebusinessresearchcompany.com/report/adaptive-radiotherapy-software-global-market-report

How Does Adaptive Radiotherapy Software Market Growth Vary Across Major Regions?
North America was the largest region in the adaptive radiotherapy software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adaptive radiotherapy software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more